Clinical Trial Update: Efficacy of Sovateltide (PMZ-1620) in Patients of Acute Ischemic Stroke [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Sovateltide (PMZ-1620) for acute ischemic stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Infarction
• Cerebral Ischemia
• Stroke Acute

Drugs mentioned

• Sovateltide (sovateltide)

Snippet

Sponsor: Pharmazz, Inc. | Conditions: Cerebral Ischemia, Cerebral Infarction | Phase 3 | Status: COMPLETED